Ronald P. DeMatteo
Impact in
- Gastroenterology top 0.01%
- Gastrointestinal Tumor Research and Treatment
- Hepatology top 0.01%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Hepatology 149
- Hepatocellular Carcinoma Treatment and Prognosis 143
- Oncology 133
- Pancreatic and Hepatic Oncology Research 68
- Co-authors
- William R. Jarnagin (251 shared papers)Yuman Fong (231 shared papers)Mithat Gönen (179 shared papers)Leslie H. Blumgart (125 shared papers)Peter J. Allen (209 shared papers)Murray F. Brennan (62 shared papers)Michael I. D’Angelica (170 shared papers)Vinod P. Balachandran (52 shared papers)
- Journals
- Annals of Surgical Oncology (79 papers)Journal of the American College of Surgeons (62 papers)Annals of Surgery (55 papers)Journal of Clinical Oncology (45 papers)HPB (36 papers)
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
Ronald P. DeMatteo
541 papers receiving 47.7k citations
Ronald P. DeMatteo's Hit Papers
Peers
Comparison fields: 5 of 168
- Gastroenterology 9.9k
- Hepatology 12.0k
- Oncology 12.5k
- Surgery 15.7k
- Pulmonary and Respiratory Medicine 11.3k
Countries citing papers authored by Ronald P. DeMatteo
This map shows the geographic impact of Ronald P. DeMatteo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald P. DeMatteo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald P. DeMatteo more than expected).
Fields of papers citing papers by Ronald P. DeMatteo
This network shows the impact of papers produced by Ronald P. DeMatteo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald P. DeMatteo. The network helps show where Ronald P. DeMatteo may publish in the future.
Co-authors
The 25 scholars most cited alongside Ronald P. DeMatteo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 556 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nomograms in oncology: more than meets the eye Hit paper breakdown → | 2015 | 2354 |
| 2 | Two Hundred Gastrointestinal Stromal Tumors Hit paper breakdown → | 2000 | 2001 |
| 3 | Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Hit paper breakdown → | 2002 | 1261 |
| 4 | Improvement in Perioperative Outcome After Hepatic Resection Hit paper breakdown → | 2002 | 1080 |
| 5 | Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma Hit paper breakdown → | 2001 | 1053 |
| 6 | Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2009 | 1014 |
| 7 | Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure Hit paper breakdown → | 2007 | 933 |
| 8 | NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors Hit paper breakdown → | 2010 | 904 |
| 9 | Intrahepatic Cholangiocarcinoma Hit paper breakdown → | 2008 | 678 |
| 10 | Acquired Resistance to Imatinib in Gastrointestinal Stromal Tumor Occurs Through Secondary Gene Mutation Hit paper breakdown → | 2005 | 668 |
| 11 | Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits Hit paper breakdown → | 2008 | 543 |
| 12 | Clinical management of gastrointestinal stromal tumors: Before and after STI-571 Hit paper breakdown → | 2002 | 503 |
| 13 | 1996 | 488 | |
| 14 | 2003 | 470 | |
| 15 | Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido Hit paper breakdown → | 2011 | 432 |
| 16 | Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST) Hit paper breakdown → | 2007 | 403 |
| 17 | 2003 | 394 | |
| 18 | 2010 | 393 | |
| 19 | Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis Hit paper breakdown → | 2009 | 387 |
| 20 | 2003 | 356 |
About Ronald P. DeMatteo
Ronald P. DeMatteo is a scholar working on Hepatology, Oncology, Surgery, Gastroenterology and Pulmonary and Respiratory Medicine, having authored 556 papers that have together received 49.3k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (143 papers), Gastrointestinal Tumor Research and Treatment (106 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (76 papers), Pancreatic and Hepatic Oncology Research (68 papers), Immune Cell Function and Interaction (33 papers), Gastric Cancer Management and Outcomes (32 papers), Sarcoma Diagnosis and Treatment (29 papers) and Immunotherapy and Immune Responses (27 papers). The work is most often cited by research in Gastroenterology (9.9k citations), Hepatology (12.0k citations), Oncology (12.5k citations), Surgery (15.7k citations) and Pulmonary and Respiratory Medicine (11.3k citations). Ronald P. DeMatteo has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include William R. Jarnagin, Yuman Fong, Mithat Gönen, Leslie H. Blumgart, Peter J. Allen, Murray F. Brennan, Michael I. D’Angelica, Vinod P. Balachandran, Michael I. D’Angelica and T. Peter Kingham. Their work appears in journals such as Annals of Surgical Oncology, Journal of the American College of Surgeons, Annals of Surgery, Journal of Clinical Oncology and HPB.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.